Pulse Biosciences to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceBusiness Wire • 02/01/22
Pulse Biosciences Announces Preliminary Fourth Quarter and Full Year 2021 Financial and Operational ResultsBusiness Wire • 01/11/22
Pulse Biosciences, Inc (PLSE)'s Technical Outlook is Bright After Key Golden CrossZacks Investment Research • 11/25/21
Pulse Biosciences to Participate in the Stephens Annual Investment ConferenceBusiness Wire • 11/18/21
Pulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/16/21
Pulse Biosciences to Present at the Stifel 2021 Virtual Healthcare ConferenceBusiness Wire • 11/04/21
Pulse Biosciences Schedules Third Quarter 2021 Financial Results Conference Call for November 15, 2021Business Wire • 11/02/21
Pulse Biosciences to Participate in the H.C. Wainwright Global Investment ConferenceBusiness Wire • 09/02/21
Pulse Biosciences Announces Appointment of Mitchell E. Levinson as Chief Strategy OfficerBusiness Wire • 08/19/21
Pulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/10/21
Pulse Biosciences Schedules Second Quarter 2021 Financial Results Conference Call for August 9, 2021Business Wire • 07/26/21
Pulse Biosciences Stock Is Trading Higher After Company's Chairman Agrees To Buy Shares Worth $50MBenzinga • 07/01/21
Pulse Biosciences® Presents Clinical Study Results of Nano-Pulse Stimulation™ Technology to Clear Benign Lesions at the American Society for Laser Medicine and Surgery (ASLMS) 2021 Virtual Annual ConferenceBusiness Wire • 05/13/21
Pulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/11/21